Using a new PET scan to find fibrosis in the body
Part of Lungs & breathing clinical trials.
This study uses a special PET scan (68Ga-1A12) to look for scarring (fibrosis) in your body. The scan may help doctors see where fibrosis is happening, which could guide your treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older, any gender.
- You have or are suspected of having a disease that causes fibrosis (scarring in organs like the lungs, liver, or kidneys).
- You are medically stable enough to have a PET scan.
- You can give informed consent (understand and sign a form) or have someone do it for you.
- You are not pregnant, breastfeeding, or have a serious infection, drug/alcohol problem, or allergy history that would make the scan unsafe.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This early (Phase 1) study compares two types of PET-CT scans to see how well they detect and measure lung scarring (pulmonary fibrosis). It may help doctors choose the best scan test for diagnosis in the future.
This trial uses a special PET scan tracer to see if it can help find and monitor diseases linked to a protein called FAP. It is for both cancer patients needing a biopsy and healthy volunteers.
This study tests whether advanced MRI scans can better detect and track lung scarring in people with certain types of pulmonary fibrosis. It may help doctors understand how well your treatment is working, without extra radiation from CT scans.
This Phase 1 study tests a radioactive imaging agent to help doctors see disease activity in the lungs using PET/MRI scans. It includes healthy volunteers and people with lung cancer, idiopathic pulmonary fibrosis, lung transplant–related lung problems, or certain medication-related lung inflammation.
This study tests a new type of PET/CT scan (FAPI-74) to see if it can detect areas of scarring (fibrosis) in the body. It may help doctors better understand and monitor conditions like certain cancers, infections after transplants, and heart inflammation.
This trial is testing a new type of PET scan (FAPI PET) to help doctors see if lung scarring (fibrosis) is getting worse or getting better. It may help decide if a treatment change is needed.
Hear when a new Pulmonary Fibrosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.